Autopsy report · NCT01117779
Tracking Renal Tumors After Cryoablation Evaluation
Cause of deathFunding or business
“Boston Scientific acquisition of BTG/Galil Medical - business decision made to stop follow-up early”
Life of this trial
- Registered 2 months before it started.
- Ran for about 10 years 4 months before it stopped.
- 246 participants enrolled.
- Results were posted on the registry 3 years 2 months after it ended.
Vital statistics
- Status
- Terminated
- Sponsor
- Boston Scientific Corporation
- Sponsor type
- Industry
- Conditions
- Kidney Neoplasms
- Interventions
- Cryoablation
- Participants
- 246
- Sites
- 7
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.